Literature DB >> 25484815

Crystal structure of 1-tosyl-1,2,3,4-tetra-hydro-quinoline.

S Jeyaseelan1, K V Asha2, G Venkateshappa3, P Raghavendrakumar3, B S Palakshamurthy2.   

Abstract

In the title compound, C16H17NO2S, the heterocyclic ring adopts a half-chair conformation and the bond-angle sum at the N atom is 350.2°. The dihedral angle between the planes of the aromatic rings is 47.74 (10)°. In the crystal, mol-ecules are linked by C-H⋯O hydrogen bonds to generate [010] chains.

Entities:  

Keywords:  C—H⋯O inter­actions; biotransformations; crystal structure; pharmacological activity; quinolines

Year:  2014        PMID: 25484815      PMCID: PMC4257240          DOI: 10.1107/S1600536814022181

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For reactions related to biotransformations, see: Leresche et al. (2006 ▶); Astudillo et al. (2009 ▶). For pharmacological activities, see: Bendale et al. (2007 ▶); Chen et al. (2007 ▶); Singer et al. (2005 ▶).

Experimental

Crystal data

C16H17NO2S M = 287.37 Monoclinic, a = 8.2176 (7) Å b = 8.0468 (6) Å c = 22.2439 (18) Å β = 98.107 (4)° V = 1456.2 (2) Å3 Z = 4 Mo Kα radiation μ = 0.22 mm−1 T = 94 K 0.24 × 0.22 × 0.18 mm

Data collection

Bruker APEXII CCD diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2013 ▶) T min = 0.949, T max = 0.961 20017 measured reflections 2568 independent reflections 2327 reflections with I > 2σ(I) R int = 0.046

Refinement

R[F 2 > 2σ(F 2)] = 0.039 wR(F 2) = 0.101 S = 1.09 2568 reflections 182 parameters H-atom parameters constrained Δρmax = 0.23 e Å−3 Δρmin = −0.37 e Å−3

Data collection: APEX2 (Bruker, 2013 ▶); cell refinement: SAINT (Bruker, 2013 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012 ▶) and Mercury (Macrae et al., 2008 ▶); software used to prepare material for publication: SHELXL97. Crystal structure: contains datablock(s) I. DOI: 10.1107/S1600536814022181/hb7292sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536814022181/hb7292Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S1600536814022181/hb7292Isup3.cml Click here for additional data file. . DOI: 10.1107/S1600536814022181/hb7292fig1.tif The mol­ecular structure of the title compound, showing displacement ellipsoids drawn at the 50% probability level. Click here for additional data file. C . DOI: 10.1107/S1600536814022181/hb7292fig2.tif The mol­ecular packing of the title compound, dashed lines indicate intra­molecular C—H⋯O and inter­molecular C—H⋯O hydrogen bonds forming C(6) chains viewed along [010]. CCDC reference: 1028050 Additional supporting information: crystallographic information; 3D view; checkCIF report
C16H17NO2SPrism
Mr = 287.37Dx = 1.311 Mg m3
Monoclinic, P21/nMelting point: 402 K
Hall symbol: -P 2ynMo Kα radiation, λ = 0.71073 Å
a = 8.2176 (7) ÅCell parameters from 2327 reflections
b = 8.0468 (6) Åθ = 1.9–25.0°
c = 22.2439 (18) ŵ = 0.22 mm1
β = 98.107 (4)°T = 94 K
V = 1456.2 (2) Å3Prism, colourless
Z = 40.24 × 0.22 × 0.18 mm
F(000) = 608
Bruker APEXII CCD diffractometer2568 independent reflections
Radiation source: fine-focus sealed tube2327 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.046
Detector resolution: 1.9 pixels mm-1θmax = 25.0°, θmin = 1.9°
phi and ω scansh = −9→9
Absorption correction: multi-scan (SADABS; Bruker, 2013)k = −9→9
Tmin = 0.949, Tmax = 0.961l = −26→26
20017 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.039Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.101H-atom parameters constrained
S = 1.09w = 1/[σ2(Fo2) + (0.0362P)2 + 0.8395P] where P = (Fo2 + 2Fc2)/3
2568 reflections(Δ/σ)max = 0.001
182 parametersΔρmax = 0.23 e Å3
0 restraintsΔρmin = −0.37 e Å3
0 constraints
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
C10.5482 (2)0.4736 (2)0.17137 (8)0.0359 (4)
C20.5261 (3)0.6396 (2)0.15480 (9)0.0461 (5)
H20.43860.70150.16750.055*
C30.6312 (3)0.7140 (3)0.12003 (10)0.0565 (6)
H30.61460.82650.10780.068*
C40.7605 (3)0.6253 (3)0.10294 (10)0.0593 (6)
H40.83190.67580.07820.071*
C50.7859 (2)0.4634 (3)0.12175 (9)0.0509 (5)
H50.87720.40430.11060.061*
C60.6818 (2)0.3838 (2)0.15666 (8)0.0400 (4)
C70.7232 (3)0.2110 (3)0.18038 (11)0.0553 (6)
H7A0.74510.13980.14610.066*
H7B0.82550.21610.20980.066*
C80.5908 (3)0.1313 (3)0.21082 (11)0.0553 (6)
H8A0.63940.04260.23860.066*
H8B0.50790.07990.17980.066*
C90.5085 (3)0.2589 (3)0.24637 (9)0.0505 (5)
H9A0.42000.20430.26510.061*
H9B0.59000.30330.27950.061*
C100.2228 (2)0.2132 (2)0.12881 (8)0.0368 (4)
C110.2794 (3)0.2300 (3)0.07339 (9)0.0536 (5)
H110.32100.33330.06160.064*
C120.2741 (4)0.0936 (3)0.03583 (10)0.0661 (7)
H120.31310.1040−0.00220.079*
C130.2137 (3)−0.0582 (3)0.05179 (10)0.0577 (6)
C140.1579 (3)−0.0714 (3)0.10703 (10)0.0524 (5)
H140.1156−0.17450.11870.063*
C150.1626 (2)0.0630 (2)0.14573 (9)0.0427 (4)
H150.12440.05200.18390.051*
C160.2090 (4)−0.2057 (4)0.00972 (13)0.0920 (10)
H16A0.2151−0.30850.03360.138*
H16B0.3025−0.2004−0.01310.138*
H16C0.1062−0.2042−0.01860.138*
O10.15775 (18)0.33842 (19)0.22946 (7)0.0548 (4)
O20.19664 (17)0.52807 (17)0.14578 (7)0.0532 (4)
N0.43800 (18)0.39748 (19)0.20781 (7)0.0381 (4)
S0.24138 (5)0.38103 (6)0.17987 (2)0.03916 (16)
U11U22U33U12U13U23
C10.0337 (9)0.0389 (10)0.0349 (9)−0.0051 (8)0.0038 (7)−0.0037 (8)
C20.0459 (11)0.0401 (11)0.0527 (11)−0.0041 (9)0.0082 (9)−0.0020 (9)
C30.0605 (14)0.0486 (12)0.0607 (13)−0.0124 (11)0.0102 (11)0.0080 (10)
C40.0523 (13)0.0752 (16)0.0527 (12)−0.0209 (12)0.0152 (10)0.0045 (12)
C50.0367 (11)0.0699 (15)0.0470 (11)−0.0057 (10)0.0092 (9)−0.0098 (11)
C60.0341 (10)0.0479 (11)0.0373 (9)−0.0024 (8)0.0025 (8)−0.0061 (8)
C70.0451 (12)0.0545 (13)0.0660 (14)0.0119 (10)0.0070 (10)−0.0018 (11)
C80.0496 (12)0.0458 (12)0.0689 (14)0.0112 (10)0.0029 (10)0.0139 (10)
C90.0495 (12)0.0565 (13)0.0457 (11)0.0021 (10)0.0074 (9)0.0137 (10)
C100.0365 (10)0.0350 (10)0.0381 (9)0.0010 (8)0.0028 (7)0.0014 (8)
C110.0704 (15)0.0471 (12)0.0444 (11)−0.0039 (11)0.0118 (10)0.0067 (9)
C120.0952 (19)0.0675 (16)0.0370 (11)0.0029 (14)0.0138 (12)−0.0015 (11)
C130.0697 (15)0.0497 (13)0.0498 (12)0.0089 (11)−0.0056 (11)−0.0092 (10)
C140.0595 (13)0.0374 (11)0.0578 (13)−0.0024 (10)−0.0002 (10)0.0005 (9)
C150.0454 (11)0.0390 (10)0.0439 (10)−0.0020 (8)0.0066 (9)0.0028 (8)
C160.127 (3)0.0716 (19)0.0739 (18)0.0083 (18)0.0008 (18)−0.0298 (15)
O10.0478 (8)0.0610 (9)0.0612 (9)−0.0083 (7)0.0268 (7)−0.0128 (7)
O20.0399 (8)0.0352 (7)0.0831 (11)0.0066 (6)0.0040 (7)0.0050 (7)
N0.0361 (8)0.0379 (8)0.0410 (8)−0.0006 (7)0.0084 (7)0.0007 (7)
S0.0332 (3)0.0345 (3)0.0516 (3)0.00026 (18)0.0119 (2)−0.0035 (2)
C1—C21.390 (3)C10—C151.378 (3)
C1—C61.392 (3)C10—C111.384 (3)
C1—N1.435 (2)C10—S1.7577 (19)
C2—C31.375 (3)C11—C121.377 (3)
C2—H20.9500C11—H110.9500
C3—C41.377 (3)C12—C131.384 (3)
C3—H30.9500C12—H120.9500
C4—C51.375 (3)C13—C141.374 (3)
C4—H40.9500C13—C161.508 (3)
C5—C61.390 (3)C14—C151.379 (3)
C5—H50.9500C14—H140.9500
C6—C71.509 (3)C15—H150.9500
C7—C81.504 (3)C16—H16A0.9800
C7—H7A0.9900C16—H16B0.9800
C7—H7B0.9900C16—H16C0.9800
C8—C91.512 (3)O1—S1.4213 (14)
C8—H8A0.9900O2—S1.4254 (14)
C8—H8B0.9900N—S1.6526 (16)
C9—N1.475 (2)S—O11.4213 (14)
C9—H9A0.9900S—O21.4254 (14)
C9—H9B0.9900
C2—C1—C6120.95 (17)H9A—C9—H9B107.9
C2—C1—N119.39 (17)C15—C10—C11120.52 (18)
C6—C1—N119.52 (17)C15—C10—S119.94 (14)
C3—C2—C1119.9 (2)C11—C10—S119.40 (15)
C3—C2—H2120.1C12—C11—C10118.5 (2)
C1—C2—H2120.1C12—C11—H11120.8
C2—C3—C4120.0 (2)C10—C11—H11120.8
C2—C3—H3120.0C11—C12—C13122.0 (2)
C4—C3—H3120.0C11—C12—H12119.0
C5—C4—C3119.8 (2)C13—C12—H12119.0
C5—C4—H4120.1C14—C13—C12118.3 (2)
C3—C4—H4120.1C14—C13—C16120.8 (2)
C4—C5—C6121.8 (2)C12—C13—C16120.9 (2)
C4—C5—H5119.1C13—C14—C15121.0 (2)
C6—C5—H5119.1C13—C14—H14119.5
C5—C6—C1117.40 (19)C15—C14—H14119.5
C5—C6—C7119.59 (18)C10—C15—C14119.75 (19)
C1—C6—C7122.88 (17)C10—C15—H15120.1
C8—C7—C6114.12 (17)C14—C15—H15120.1
C8—C7—H7A108.7C13—C16—H16A109.5
C6—C7—H7A108.7C13—C16—H16B109.5
C8—C7—H7B108.7H16A—C16—H16B109.5
C6—C7—H7B108.7C13—C16—H16C109.5
H7A—C7—H7B107.6H16A—C16—H16C109.5
C7—C8—C9110.59 (19)H16B—C16—H16C109.5
C7—C8—H8A109.5C1—N—C9115.09 (15)
C9—C8—H8A109.5C1—N—S118.90 (12)
C7—C8—H8B109.5C9—N—S116.17 (13)
C9—C8—H8B109.5O1—S—O2119.76 (9)
H8A—C8—H8B108.1O1—S—N106.36 (9)
N—C9—C8112.16 (16)O2—S—N107.38 (8)
N—C9—H9A109.2O1—S—C10107.98 (9)
C8—C9—H9A109.2O2—S—C10107.57 (9)
N—C9—H9B109.2N—S—C10107.19 (8)
C8—C9—H9B109.2
D—H···AD—HH···AD···AD—H···A
C14—H14···O2i0.952.533.340 (2)143
Table 1

Hydrogen-bond geometry (, )

DHA DHHA D A DHA
C14H14O2i 0.952.533.340(2)143

Symmetry code: (i) .

  4 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  8-Substituted 3,4-dihydroquinolinones as a novel scaffold for atypical antipsychotic activity.

Authors:  Jamie M Singer; Bridget M Barr; Linda L Coughenour; Tracy F Gregory; Michael A Walters
Journal:  Bioorg Med Chem Lett       Date:  2005-10-15       Impact factor: 2.823

3.  Aza analogues of equol: novel ligands for estrogen receptor beta.

Authors:  Wuhong Chen; Zhaohu Lin; Mengmeng Ning; Chunhao Yang; Xueming Yan; Yuyuan Xie; Xu Shen; Ming-Wei Wang
Journal:  Bioorg Med Chem       Date:  2007-06-06       Impact factor: 3.641

4.  Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarials.

Authors:  Pravin Bendale; Srinivas Olepu; Praveen Kumar Suryadevara; Vivek Bulbule; Kasey Rivas; Laxman Nallan; Brian Smart; Kohei Yokoyama; Sudha Ankala; Prakash Rao Pendyala; David Floyd; Louis J Lombardo; David K Williams; Frederick S Buckner; Debopam Chakrabarti; Christophe L M J Verlinde; Wesley C Van Voorhis; Michael H Gelb
Journal:  J Med Chem       Date:  2007-08-28       Impact factor: 7.446

  4 in total
  3 in total

1.  Crystal structure of 1-methane-sulfonyl-1,2,3,4-tetra-hydro-quinoline.

Authors:  S Jeyaseelan; S L Nagendra Babu; G Venkateshappa; P Raghavendra Kumar; B S Palakshamurthy
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-01-01

2.  Crystal structure of 1-[(6-chloro-pyridin-3-yl)sulfon-yl]-1,2,3,4-tetra-hydro-quinoline.

Authors:  S Jeyaseelan; H R Rajegowda; R Britto Dominic Rayan; P Raghavendra Kumar; B S Palakshamurthy
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-05-23

3.  Crystal structure of 1-benzyl-sulfonyl-1,2,3,4-tetra-hydro-quinoline.

Authors:  S Jeyaseelan; B R Sowmya; G Venkateshappa; P Raghavendra Kumar; B S Palakshamurthy
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-03-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.